TRHC stock forecast
Our latest prediction for Tabula Rasa Healthcare, Inc.'s stock price was made on the Dec. 18, 2019 when the stock price was at 43.76$.
In the short term (2weeks), TRHC's stock price should underperform the market by -4.74%. During that period the price should oscillate between -9.89% and +7.26%.
In the medium term (3months), TRHC's stock price should underperform the market by -12.28%. During that period the price should oscillate between -29.43% and +15.50%.Get email alerts
About Tabula Rasa Healthcare, Inc.
Tabula Rasa Healthcare, Inc. engages in the development of pharmaceutical software that optimizes medication regimens. It offers cloud-based applications, such as EireneRx and MedWise Advisor. The company was founded by Calvin H. Knowlton and Orsula V. Knowlton in April 2009 and is headquartered in Moorestown, NJ.
At the moment the company generates 269M USD in revenues.
On its last earning announcement, the company reported a loss of -1.80$ per share.
The book value per share is 3.95$
Three months stock forecastDec. 18, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|